CSIMarket Company Name, Ticker, Customers, else..
 
Xtant Medical Holdings Inc   (NYSEAMER: XTNT)
 
Price: $0.3750 $-0.03 -6.250%
Day's High: $0.40139999985694885 Week Perf: -3.85 %
Day's Low: $ 0.37 30 Day Perf: -14.77 %
Volume (M): 378,626 52 Wk High: $ 0.95
Volume (M$): $ 0 52 Wk Avg: $0.57
Open: $0.39 52 Wk Low: $0.27



 Market Capitalization (Millions $) 53
 Shares Outstanding (Millions) 140
 Employees 151
 Revenues (TTM) (Millions $) 109
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 1

Business Description


Xtant Medical Holdings Inc is a medical devices company that specializes in the design, development, and commercialization of regenerative medicine products and medical implant products. The company offers a wide range of products for orthopedic and neurological surgeries, including spinal implants, biologics, and orthobiologics. Xtant Medical Holdings Inc is focused on improving patient outcomes and quality of life through innovative solutions and technologies. The company operates globally and collaborates with healthcare professionals, hospitals, and medical institutions to provide effective and reliable solutions for various medical conditions.


   Company Address: 664 Cruiser Lane Belgrade 59714 MT
   Company Phone Number: 388-0480   Stock Exchange / Ticker: NYSEAMER XTNT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IART   -1.01%    
JNJ        2.68% 
MDT        3.22% 
SYK   -8.33%    
• View Complete Report
   



Product Service News

Xtant Medical Leaps Forward: Introduces SimpliGraft and SimpliMax for Advanced Wound Care

Published Tue, Apr 30 2024 9:00 AM UTC

With the advent of continuous innovation, the face of medical treatments is ever-changing. One company making strides in the field is Xtant Medical Holdings, Inc., a prominent global name in the medical technology industry known for its advanced surgical solutions for spinal disorders. Continuing with their role as trailblazers, Xtant recently announced the full commercial l...
Financing Agreement

Xtant Medical Fortifies Financial Foundation with $17 Million Revolving Credit Facility Expansion

Published Thu, Mar 7 2024 9:05 PM UTC

Xtant Medical Holdings, Inc. Expands Financing Options to Fuel Growth
BELGRADE, Mont., March 07, 2024 - Xtant Medical Holdings, Inc. (NYSE American: XTNT) has made significant moves to strengthen its financial position and support its growth strategy in the spinal surgery solutions market. The company recently announced amendments to its revolving credit agreement and te...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.48
Price to Sales (Expected) -
Price to Book 1.31
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.33
Working Capital Ratio 2.15
Leverage Ratio (MRQ) 0.99
Total Debt to Equity 0.28
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.08 $
Revenues (TTM) 0.78 $
Cash Flow (TTM) 0.04 $
Cash 0.07 $
Book Value 0.29 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 720,185
Net Income per Employee (TTM) -73,755
Receivable Turnover Ratio (TTM) 5.44
Inventory Turnover Ratio (TTM) 1.28
Asset Turnover Ratio (TTM) 1.16

Profitability Ratios Current
Gross Margin (MRQ) 57.88 %
Operating Margin (MRQ) -39.81 %
Net Margin (MRQ) -40.87 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Xtant Medical Holdings Inc's Segments
Non-US    0.87 % of total Revenue
Product    190.68 % of total Revenue
Orthobiologics    143.15 % of total Revenue
Spinal Implant    47.53 % of total Revenue
US    187.44 % of total Revenue
Non Us    3.24 % of total Revenue

  Xtant Medical Holdings Inc Outlook

On April 1 2024 the Xtant Medical Holdings Inc provided following guidance

Xtant Medical Holdings Inc. has reported a record-breaking full year revenue of $91.3 million for 2023. The company is now setting its sights even higher for the upcoming year, with a revenue guidance range of $112 million to $11...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.